Innovative Dosage Forms (eBook)
XVIII, 452 Seiten
Wiley-VCH Verlag GmbH & Co. KGaA
978-3-527-81218-9 (ISBN)
This highly accessible, practice-oriented book examines current approaches in the development of drug formulations for preclinical and clinical studies, including the use of functional excipients to enhance solubility and stability. It covers oral, intravenous, topical, and parenteral administration routes. The book also discusses safety aspects of drugs and excipients, as well as regulatory issues relevant to formulation.
Innovative Dosage Forms: Design and Development at Early Stage starts with a look at the impact of the polymorphic form of drugs on the preformulation and formulation development. It then offers readers reliable strategies for the formulation development of poorly soluble drugs. The book also studies the role of reactive impurities from the excipients on the formulation shelf life; preclinical formulation assessment of new chemical entities; and regulatory aspects for formulation design. Other chapters cover innovative formulations for special indications, including oncology injectables, delayed release and depot formulations; accessing pharmacokinetics of various dosage forms; physical characterization techniques to assess amorphous nature; novel formulations for protein oral dosage; and more.
-Provides information that is essential for the drug development effort
-Presents the latest advances in the field and describes in detail innovative formulations, such as nanosuspensions, micelles, and cocrystals
-Describes current approaches in early pre-formulation to achieve the best in vivo results
-Addresses regulatory and safety aspects, which are key considerations for pharmaceutical companies
-Includes case studies from recent drug development programs to illustrate the practical challenges of preformulation design
Innovative Dosage Forms: Design and Development at Early Stage provides valuable benefits to interdisciplinary drug discovery teams working in industry and academia and will appeal to medicinal chemists, pharmaceutical chemists, and pharmacologists.
Yogeshwar Bachhav, PhD, is currently working as consultant to the pharmaceutical industry in Europe and Asia supporting the pharmaceutical development of new and approved drugs. He is a pharmacist by training and completed a PhD at the Institute of Chemical Technology, Matunga, Mumbai (India) in 2007. He has worked in Europe for more than 10 years with different start-up and mid-sized biotech/pharmaceutical companies. During this tenure, he has successfully managed pharmaceutical development of several projects from POC to phase 1, 2 and 3 clinical trials.
Impact of the polymorphic form of the drugs/NCEs on the preformulation and formulation development
Strategies for the formulation development of poorly soluble drugs via oral route
Effect of residual reactive impurities in excipients on the stability of pharmaceutical products
Preclinical formulation assessment of NCEs
Innovative dosage forms - design and development at early stage
Insight into innovative applications of parenteral formulations
Assessing pharmacokinetics of various dosage forms at early stage
Medical devices: Formulation aspects
Physical characterization techniques to assess amorphous nature
Design and development of ocular formulations for preclinical and clinical trials
Preclinical safety aspects for excipients: Oral, IV and topical routes
Formulation of therapeutic proteins: strategies for developing oral protein formulations
Erscheint lt. Verlag | 20.8.2019 |
---|---|
Reihe/Serie | Methods and Principles in Medicinal Chemistry | Methods and Principles in Medicinal Chemistry |
Mitarbeit |
Herausgeber (Serie): Raimund Mannhold, Helmut Buschmann, Jörg Holenz |
Sprache | englisch |
Themenwelt | Naturwissenschaften ► Chemie |
Schlagworte | Chemie • Chemistry • Drug Formulation & Delivery • Medical Science • Medizin • nanomedicine • Nanomedizin • Nanotechnologie • nanotechnology • Pharmacology & Pharmaceutical Medicine • Pharmakologie • Pharmakologie u. Pharmazeutische Medizin • Wirkstoffformulierung, Wirkstofftransport |
ISBN-10 | 3-527-81218-0 / 3527812180 |
ISBN-13 | 978-3-527-81218-9 / 9783527812189 |
Haben Sie eine Frage zum Produkt? |
Größe: 15,1 MB
Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM
Dateiformat: EPUB (Electronic Publication)
EPUB ist ein offener Standard für eBooks und eignet sich besonders zur Darstellung von Belletristik und Sachbüchern. Der Fließtext wird dynamisch an die Display- und Schriftgröße angepasst. Auch für mobile Lesegeräte ist EPUB daher gut geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine
Geräteliste und zusätzliche Hinweise
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich